Sequent Scientific Share Price

Sequent Scientific Share Price

NSE: VIYASH
|
Pharmaceuticals
|
S Cap
₹ 253.75
+₹2.25 (0.89%)
1D
Last updated 23 Sep, 2026, 15:57 IST

Sequent Scientific Share Price Today

As of 23 Sep 2026, Sequent Scientific share price is ₹253.75. The stock opened at ₹252.90, compared to its previous close of ₹251.50. During today's trading session, Sequent Scientific share price moved in the range of ₹251.50 to ₹257.45, with an average price of ₹254.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹178.13 and a high of ₹298.00. On the performance front, Sequent Scientific share price has increased by 33.47% over the last six months and is up 23.53% on a year-on-year basis.

₹251.50
0.89% up today
₹257.45
1D LOW
1D HIGH

Sequent Scientific Returns Calculator

Circuit
L
H
₹201.20
₹301.80
52-week
L
H
₹178.13
₹298.00

About Sequent Scientific

Sequent Scientific Share Price
ISIN
INE807F01027
Sector Market Cap
₹ 11,120.18 Cr

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.

Sequent Scientific Financial Highlights

  • Revenue: Sequent Scientific reported revenue of ₹3,463.86 crore in FY26 vs ₹3,039.73 crore in FY25. It showed an increase of 13.95% on a yearly basis.
  • Operating Profit: Sequent Scientific reported an operating profit of ₹349.02 crore in FY26 vs ₹13.18 crore in FY25. It showed an increase of 2,548.10% on a year-on-year basis.
  • Net Profit: Sequent Scientific reported a net profit of ₹224.65 crore in FY26 vs ₹15.77 crore in FY25. It showed an increase of 1,324.54% on a yearly basis.

Sequent Scientific Quarterly Result Highlights

  • Sequent Scientific reported revenue of ₹954.67 crore in Jun 2026, compared with ₹935.88 crore in Mar 2026, representing an increase of 2.01% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported an operating profit of ₹112.41 crore in Jun 2026, compared with ₹125.24 crore in Mar 2026, representing a decrease of 10.24% on a quarter-on-quarter (QoQ) basis.
  • Sequent Scientific reported a profit of ₹79.29 crore in Jun 2026, compared with ₹66.38 crore in Mar 2026, reflecting an increase of 19.45% on a QoQ basis.
  • The earnings per share (EPS) of Sequent Scientific stood at ₹4.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
61.31%
FII
4.50%
Other DII
0.83%
Retail and other
30.44%
Mutual funds
2.93%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20255.91%
Dec 20253.16%
Mar 20262.94%
Jun 20264.50%
Mkt Cap Cr
11,109.10
P/E
41.58
P/B
3.94
ROE
7.07%
D/E
0.01
ROCE
13.01%
Div. Yield
0.00%
EPS(TTM)
1.75
Turnover
0.39
EV/EBITDA
15.87
Net Margin
7.56%
Op. Margin
21.74%
ROA
5.77%
Quick Ratio
1.61
Curr. Ratio
2.47
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Viyash Scientific has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Viyash Scientific appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Viyash Scientific revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sequent Scientific Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,420.31₹3,006.84₹1,369.73₹1,420.91
Other Income₹43.55₹32.89₹10.96₹6.39
Total Revenue₹3,463.86₹3,039.73₹1,380.69₹1,427.30
Total Expenses₹3,070.63₹2,944.99₹1,417.94₹1,500.16
Profit Before Tax₹349.03₹13.18-₹54.65-₹137.66
Tax₹124.37-₹2.59-₹25.03-₹15.68
Profit After Tax₹224.65₹15.77-₹29.61-₹121.98
EPS - Basic₹4.09₹0.54-₹1.44-₹4.88
EPS - Diluted₹4.01₹0.53-₹1.44-₹4.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹349.03₹13.18-₹54.65-₹137.66
Income before WC changes₹713.41₹467.81₹90.32₹83.06
Change in Assets-₹388.10-₹183.62-₹8.54-₹34.60
Change in Liabilities₹58.94₹109.48-₹37.14-₹17.01
Change in WC-₹329.16-₹74.15-₹45.67-₹51.61
Cash flow from Operations₹322.91₹344.80₹30.60₹16.81
Cash flow from Investing-₹84.12-₹447.22-₹5.92-₹64.96
Cash flow from Financing-₹123.33₹87.04-₹1.44₹32.23
Total Cash Flow₹115.46-₹15.38₹23.24-₹15.92
Cash (Start of the year)₹140.30₹156.18₹41.57₹57.50
Cash (End of the year)₹255.76₹140.30₹64.81₹41.57

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,373.84₹2,349.48₹729.45₹749.33
Current Assets₹2,254.55₹1,782.79₹810.94₹779.79
Total Assets₹4,628.39₹4,132.27₹1,540.38₹1,529.12
Current Liabilities₹945.90₹1,015.11₹626.99₹558.76
Net Current Asset₹1,308.65₹767.67₹183.95₹221.04
Non-Current Liabilities₹567.76₹552.22₹200.44₹221.18
Equity Capital₹3,114.73₹2,564.94₹712.96₹749.19
Total Equity & Liabilities₹4,628.39₹4,132.27₹1,540.38₹1,529.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,382.06₹1,310.34₹168.52₹222.69
Other Income₹66.26₹72.21₹45.98₹28.24
Total Revenue₹1,448.32₹1,382.55₹214.50₹250.93
Total Expenses₹1,287.89₹1,251.92₹208.48₹260.67
Profit Before Tax₹116.22₹49.17-₹0.24-₹9.75
Tax₹40.35-₹9.32-₹0.86-₹3.67
Profit After Tax₹75.87₹58.49₹0.62-₹6.08
EPS - Basic₹1.75₹1.36₹0.03-₹0.24
EPS - Diluted₹1.72₹1.34₹0.03-₹0.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹116.22₹49.17-₹0.24-₹9.75
Income before WC changes₹262.77₹269.97-₹18.43-₹10.23
Change in Assets-₹93.64-₹121.74-₹11.45₹71.40
Change in Liabilities-₹38.71₹57.46₹0.67-₹22.72
Change in WC-₹132.35-₹64.28-₹10.77₹48.68
Cash flow from Operations₹119.12₹187.95-₹26.94₹37.75
Cash flow from Investing-₹106.88-₹410.18₹5.47-₹50.70
Cash flow from Financing-₹7.06₹195.38₹22.32₹0.24
Total Cash Flow₹5.18-₹26.85₹0.84-₹12.71
Cash (Start of the year)₹15.79₹43.15₹0.08₹12.80
Cash (End of the year)₹20.97₹15.79₹0.93₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,692.59₹2,680.41₹1,090.82₹1,047.75
Current Assets₹962.45₹839.33₹96.78₹75.02
Total Assets₹3,655.04₹3,519.73₹1,187.60₹1,122.77
Current Liabilities₹415.77₹509.10₹98.16₹61.61
Net Current Asset₹546.68₹330.22-₹1.38₹13.42
Non-Current Liabilities₹50.20₹102.22₹2.21₹2.80
Equity Capital₹3,189.07₹2,908.41₹1,087.23₹1,058.36
Total Equity & Liabilities₹3,655.04₹3,519.73₹1,187.60₹1,122.77
* All values are in INR Crore
Qty
Bid
9352
253.75
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 9352
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.55
Neutral
ATR (14)
7.65
Neutral
STOCH(9,6)
55.18
Neutral
STOCH RSI (14)
64.84
Neutral
ADX(9)
24.77
Bearish
UO(9)
41.61
Neutral
ROC(12)
-3.44
Bearish
WillR(14)
-53.42
Neutral
Period
Simple value
Exponential vaue
5D
247.23
250.32
10D
252.5
252.36
20D
258.43
256.18
50D
262.1
259.03
100D
256.71
251.98
Volume trend — traded volume by day
23 Sep19L
22 Sep45L
21 Sep16L
18 Sep14L
17 Sep27L
16 Sep63L
Average31L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Sequent Scientific Share Price
Sequent Scientific
Pharmaceuticals
Add Stock
Add Another

Sequent Scientific Share Price FAQs

Sequent Scientific share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837